Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta Full Text
Indian Journal of Ophthalmology, 05/11/2012
Rishi P et al. – A 12–year–old girl, diagnosed of osteogenesis imperfecta, presented with sudden visual loss in the left eye. Investigations revealed an active choroidal neovascular membrane. She underwent treatment with intravitreal Bevacizumab. Follow–up at 1 month revealed the development of lacquer crack running through the macula, underlying the fovea. The patient received two re–treatments at 1–month intervals, following which the choroidal neovascularization (CNV) regressed completely.